Clinical trial
Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan
NCT00009542 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00009542 |
|---|---|
| Title | Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan |
| Official title | Evaluation of the Effect of Kava on Drug Metabolism Enzymes and EEG Measured Beta Amplitude |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | kava (Piper methysticum) |
| Enrollment | 20 |
| Start date | Jan 1, 2001 |
| Completion | Apr 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: